By Anna MacDonald and Sarah Whelan – Technology Networks
Cell and gene therapy is a field of personalized medicine, driving the innovation of medicine and revolutionizing the way we treat disease.
Gene therapies use DNA or other genetic material to edit a patient’s cells to treat inherited or acquired diseases, and cell therapies involve the transfer of whole cells into a patient which replace those affected by disease.
At the time of writing, the US Food and Drug Administration has approved the use of 25 cell and gene therapies, with many more under assessment in clinical trials.
To learn more about the field of cell and gene therapy and discuss some of the challenges facing the industry and the benefits that automation can bring.